Extensive Experience And Continuous Development For Healthcare Technology
Bittium's Clinical Advisory Board consists of medical professionals outside the company, each with extensive experience in their specialties, such as sports medicine, cardiology, electrophysiology, and clinical research. The Clinical Advisory Board supports Bittium's healthcare technology product business, and brings Bittium medical expertise and an international forum for continuous development.
Enhancing performance has always been in the focus of Lutz Graumann’s work. Starting his medical career in 1994 he soon realized that his desires in the professional field were close to those of his private life: sports.
Challenges dominated his work and private life after accepting a full scholarship of the German Bundeswehr.
Working with different pro athletes, special forces, fighter, pilots and leadership groups, he has learned that training methods and nutritional concepts have varying impacts on the individual.
Dr. Graumann integrates sports and military medicine and cutting-edge technology to create data based movement, nutrition, recovery and mindset strategies for work and play.
Dr. De Bie recently retired from his position as Chief Scientist, Cardiology at Baxter Inc. where he was leading a team in the development of algorithms for ECG analysis and multi-parameter Patient Monitoring. Previously he acted as a Senior Vice President of Engineering and Director of Engineering at Mortara Instrument’s European development facility.
During his 30-year tenure, Dr. De Bie has contributed to many developments and validation efforts in the industry and authored or co-authored numerous publications, often in cooperation with medical and scientific institutions. He has served in the board of the “International Society of Computerized Electrocardiology” and co-hosted the 2008 edition of the annual “Computing in Cardiology” conference in Bologna.
Dr. De Bie currently teaches biomedical engineering MSc students at the University of Bologna.
Dr. Amraotkar is a physician-scientist with years of experience in academic clinical research. His research interest is in acute myocardial infarction and other mechanisms of cardiovascular injury, especially environmental factors like air pollution.
He has expertise in early-stage development of clinical studies, lifecycle management (conception-to-completion), and recruitment for challenging study designs. Most recently, he is serving as the clinical principal investigator of NIH funded phase II placebo-controlled randomized clinical trial.
Dr. Amraotkar is an active scientific reviewer for multiple PubMed indexed peer-reviewed journals and serves on two committees with the American Heart Association (ATVB Council Membership Committee and ATVB Council Diversity Committee). Dr. Amraotkar is also on the Editorial Board of the American Journal of Medicine.
Dr. Paavonen is a Finnish cardiologist who works in the private healthcare company Terveystalo. He currently works in conservative cardiology, and his tasks include supervising cardiology services and the analysis of up to 1000 ambulatory ECGs using Bittium hardware and software. He has acted as an advisor to Bittium Biosignals for several years.
Before joining Terveystalo, Dr. Paavonen worked at the Helsinki University Hospital as an electrophysiologist from 2011 to 2016. His work included pacemaker work, including implantations, and electrophysiology, including ablations of various arrhythmias. His dissertation in 2006 focused on the long QT syndrome.